Greetings as the days get shorter. Thanks to all the people who turned out for our last Wellington seminar on February 21. Dr Rob Weinkove delivered...
News
Companies Collaborating to Use ClonoSEQ Assay in Multiple Myeloma Trials Testing Isatuximab
Adaptive Biotechnologies is collaborating with Sanofi to use its clonoSEQ Assay for measuring minimal residual disease in multiple myeloma patients...
Elotuzumab/Pomalidomide Prolongs PFS in Pretreated Multiple Myeloma
The addition of elotuzumab (Empliciti) to pomalidomide (Pomalyst) and dexamethasone cut the risk of disease progression or death by 46% compared...
Once weekly versus twice weekly carfilzomib dosing in patients with relapsed and refractory multiple myeloma
Once weekly versus twice weekly carfilzomib dosing in patients with relapsed and refractory multiple myeloma (A.R.R.O.W.): interim analysis results...
Early Results Suggest That Once-Weekly, High-Dose Carfilzomib Prolongs PFS in Multiple Myeloma
Administering carfilzomib once a week significantly improves progression-free survival (PFS) and toxicity compared with twice a week among patients...
Bluebird myeloma treatment delays cancer progression: trial
CHICAGO (Reuters) - Patients with advanced multiple myeloma treated with bluebird bio’s experimental immunotherapy lived for a median of nearly a...
Researchers discover myeloma treatment delays cancer progression
CHICAGO: Patients with advanced multiple myeloma treated with bluebird bio’s experimental immunotherapy lived for a median of nearly a year before...
Myeloma Summit 2018
Differences in Multiple Myeloma are Key to Treatment Options
When diagnosing patients with multiple myeloma, it is important to identify the specific stage, mutations and risk level of the disease to determine...
Watch: CAR T-Cell Therapy: a New Frontier in Blood Cancer Treatment
CAR T-Cell Therapy: a New Frontier in Blood Cancer Treatment Dr Rob Weinkove spoke at our patient seminar on CAR T-Cell Therapy: a New Frontier in...
Myeloma Minute – Speeding Myeloma Research
Take a look at the International Myeloma Foundation's Newsletter, the Myeloma Minute
Terminally ill dad saves more than $200k bringing in cancer drugs from India
A Kiwi dad who's dying of lung cancer has been bypassing the Pharmac system to get cheap pharmaceuticals directly from India - and says thousands of...